Partner Content Partner Content Spotlight on Key Sessions You Cannot Miss at Ophthalmic Drug... Are you aware the ophthalmic market is expected to reach $21 billion by the year 2022?
News CEPI-backed trial of Rift Valley fever jab starts in Kenya A promising vaccine candidate for Rift Valley fever (RVF) has been advanced into a phase 2 trial in Kenya, the first time that a shot has reached this stage of development in a country wher
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.